Top compounds associated with response to EIF2S3


Feature Type Standardized
Nominal ANOVA
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA niclosamide CTRPv2 pan-cancer AAC 0.12 0.001
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.12 0.001
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.17 0.001
mRNA JNK-9L GDSC1000 pan-cancer AAC 0.12 0.002
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV